Clinical Manual of Child and Adolescent Psychopharmacology, Fourth Edition

Updated to include a succinct yet thorough review of the most recent evidence-based information and data-driven best treatment practices in child and adolescent psychiatry, this fourth edition of the Clinical Manual of Child and Adolescent Psychopharmacology not only examines the evidence for treating mental health disorders in younger patients but also illuminates how clinical trials of various methodologies can inform different aspects of clinical practice. Organized by DSM-5-TR diagnosis rather than drug class, this clinically accessible volume offers an exhaustive analysis of the use of psychotropic agents in disorders that include: Attention-deficit/hyperactivity disorder, Depressive disorders, Autism spectrum disorder, Early schizophrenia and psychotic illnesses, Eating disorders. Comprehensive medication tables allow for easy reference of dosing, side effects, and tips for management. Additionally, key points at the conclusion of each chapter summarize essential information for treating clinicians. With a depth of information unmatched by any other guide, this new edition of the Clinical Manual of Child and Adolescent Psychopharmacology is an indispensable desktop reference for clinicians working with young patients Cover Half Title Title Copyright Contents List of Tables List of Figures Contributors Foreword Preface 1 Developmental Aspects of Pediatric Psychopharmacology Pharmacokinetics and Metabolism Pharmacodynamics Efficacy Safety Ethical Aspects Regulatory Aspects Conclusion 2 Attention-Deficit/Hyperactivity Disorder Diagnosis Treatment Role of Nonstimulant Medication in the Treatment of ADHD Monitoring Treatment Choice of Medication Conclusion 3 Disruptive Behavior Disorders and Aggression Epidemiology Differential Diagnosis Course and Outcome Rationale and Justification for Psychopharmacological Treatment Review of Treatment Studies Safety Issues Practical Management Strategies Conclusion 4 Anxiety Disorders Epidemiology Course and Outcome Rationale and Justification for Psychopharmacological Treatment Medications for Pediatric Anxiety Disorders: Review of Treatment Studies Safety Issues Practical Management Strategies: Treatment Approaches, Algorithms, and Guidelines Conclusion 5 Major Depressive Disorder Assessment of Treatment Response Treatment Phases Treatment of MDD With Selective Serotonin Reuptake Inhibitors and Other Novel Antidepressants Treatment of Major Depressive Disorder Subtypes and Bipolar Depression Treatment of Comorbid Conditions and Suicidality Continuation Therapy Maintenance Therapy 6 Bipolar Disorders Treatment of Acute Manic or Mixed States Maintenance Therapy Treatment of Pediatric Bipolar Depression Combination Pharmacotherapy Conclusion 7 Autism Spectrum Disorder Atypical Antipsychotics Serotonin Reuptake Inhibitors Psychostimulants Other Drug Treatments for ADHD Mood Stabilizers Cholinesterase Inhibitors Glutamatergic Agents Other Compounds Safety Issues Practical Management Strategies 8 Tic Disorders Epidemiology Diagnosis and Assessment Treatment of Tics in Children With Tourette's Disorder Comorbid Illnesses With Tics or Tourette's Disorder Conclusion 9 Early-Onset Schizophrenia and Psychotic Illnesses History and Classification of Psychosis in Children Epidemiology Course and Outcome Rationale for Psychopharmacological Treatment Pharmacotherapy Treatment of Comorbid Conditions Treatment of Side Effects Early Intervention Studies Conclusion 10 Eating Disorders Anorexia Nervosa Bulimia Nervosa Binge-Eating Disorder Avoidant/Restrictive Food Intake Disorder Pica Rumination Disorder Conclusion Index Back Cover